Genmab — Februar 2023

deleted-user

Det kan godt være, at jeg køber flere i morgen eller måske næste uge. Det må tiden vise

Pensionisten

ProinvestorNEWS

Hvad er en Rasmus Modsat-investering, hvad betyder skuffende tysk vækst, bliver Bavarian Nordics covid-19 muligheder ringere? Det bliver vendt af Hansen & Larsen i ugens podcast, som selvfølgelig også kommer ind på nyt regnskab fra Novo Nordisk, som der stadig ikke er nogen over eller ved siden af. https://www.proinvestor.com/boards/109987

Helge_LarsenPI-redaktør

Godmorgen.

Stroka

God morgen

bibob

God morgen.

bibob

OncLive. D- Rd. Pollux. https://www.onclive.com/view/daratumumab-lenalidomide-dexamethasone-improves-os-in-relapsed-refractory-multiple-myeloma?utm_source=sfmc&utm_medium=email&utm_campaign=02012023_OncLive_SAN-23-OSD1504_Global MM CC_Sanofi Sarclisa - Denmark&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

bibob

Just a moment...

(www.onclive.com)

bibob

https://www.onclive.com/view/chari-spotlights-efficacy-of-talquetamab-and-next-steps-for-exploration-in-r-r-multiple-myeloma?utm_source=sfmc&utm_medium=email&utm_campaign=%25%25emailname_%25%25&eKey=%25%25eKey%25%25&utm_source=sfmc&utm_medium=email&utm_campaign=02012023_OncLive_SAN-23-OSD1504_Global MM CC_Sanofi Sarclisa - Denmark&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

bibob

Just a moment...

(www.onclive.com)

Bulder

Tak bibob

AaBforever

Bundvending...snart...
?

E_L

Novartis Ag (NVS) Q4 2022 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2023/02/01/novartis-ag-nvs-q4-2022-earnings-call-transcript/ for Kesimpta

E_L

Understanding the Role of CD20-CD3 https://www.hmpgloballearningnetwork.com/site/onc/biological-pathways-reviews/cd20-cd3

E_L

has anyone seen prognoses for Kesimpta sales for 2023? i underestimated this for '22, but even this strong year was mainly US so there should still be strong growth this year with Europe coming in

Sukkeralf

Based on q4 sales its looks like at least 1,5 billion in 2023

E_L

yes, and i guess we should add some growth in europe
to that

Solsen

Ocrevus p 29 https://assets.cwp.roche.com/f/126832/x/0ef4d462d9/irp230202-a.pdf with +1,5 bn CHF in Q4

Bulder

Hm, 6 mdrs
sc ocrevus på vej

Bulder

Den bliver svær, hvis de kommer med gode data.